EUVIMEDEUVIMED entdecken
Open Access

Simulated drug disposition in critically ill patients to evaluate effective PK/PD targets for combating Pseudomonas aeruginosa resistance to meropenem

Xiaonan Zhang, Yan Wang, Sanwang Li, Feifan Xie iD, Hanxi Yi iD

Antimicrobial Agents and Chemotherapy · 2024

DOI: 10.1128/aac.01541-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Xiaonan Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Biopharmaceutics and Pharmacokinetics, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Pseudomonas Infections. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Science and Technology Innovation Program of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bacterial infections, including those caused by Pseudomonas aeruginosa , often lead to sepsis, necessitating effective antibiotic treatment like carbapenems. The key pharmacokinetic/pharmacodynamic (PK/PD) index correlated to carbapenem efficacy is the fraction time of unbound plasma concentration above the minimum inhibitory concentration (MIC) of the pathogen (% fT > MIC). While multiple targets exist, determining the most effective one for critically ill patients remains a matter of debate. This study evaluated meropenem’s bactericidal potency and its ability to combat drug resistance in Pseudomonas aeruginosa under three representative PK/PD targets: 40% fT > MIC, 100% fT > MIC, and 100% fT > 4× MIC. The hollow fiber infection model (HFIM) was constructed, validated, and subsequently inoculated with a substantial Pseudomonas aeruginosa load (1 × 10 8 CFU/mL). Different meropenem regimens were administered to achieve the specified PK/PD targets. At specified intervals, samples were collected from the HFIM system and subjected to centrifugation. The resulting supernatant was utilized to determine drug concentrations, while the precipitates were used to track changes in both total and drug-resistant bacterial populations over time by the spread plate method. The HFIM accurately reproduced meropenem’s pharmacokinetics in critically ill patients. All three PK/PD target groups exhibited a rapid bactericidal response within 6 h of the initial treatment. However, the 40% fT > MIC and 100% fT > MIC groups subsequently showed bacterial resurgence and resistance, whereas the 100% fT > 4× MIC group displayed sustained bactericidal activity with no evidence of drug resistance. The HFIM system revealed that maintaining 100% fT > 4× MIC offers a desirable microbiological response for critically ill patients, demonstrating strong bactericidal capacity and effective prevention of drug resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pseudomonas aeruginosaPseudomonas InfectionsHumansMeropenemCritical IllnessAnti-Bacterial AgentsCarbapenemsMicrobial Sensitivity Tests

Stichwörter der Autor:innen

PK/PDPseudomonas aeruginosahollow fiber infection modelmeropenemsepsis

Substanzen

MeropenemAnti-Bacterial AgentsCarbapenems

Autor:innen und Institutionen

  • Division of Biopharmaceutics and Pharmacokinetics, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.
  • Yueyang Inspection and Testing Center, Yueyang, China.
  • Department of Pharmacy, The Second Xiangya Hospital, Central South University, Changsha, China.
  • Department of Pathology, School of Basic Medical Science, Central South University, Changsha, China.

ORCID-Profile: Feifan Xie, Hanxi Yi

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • Science and Technology Innovation Program of Hunan Province

Zitieren

APA

Zhang, X., Wang, Y., Li, S., Xie, F., & Yi, H. (2024). Simulated drug disposition in critically ill patients to evaluate effective PK/PD targets for combating Pseudomonas aeruginosa resistance to meropenem. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.01541-23

Vancouver

Zhang X, Wang Y, Li S, Xie F, Yi H. Simulated drug disposition in critically ill patients to evaluate effective PK/PD targets for combating Pseudomonas aeruginosa resistance to meropenem. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.01541-23

BibTeX
@article{Zhang2024,
  author = {Zhang, Xiaonan and Wang, Yan and Li, Sanwang and Xie, Feifan and Yi, Hanxi},
  title = {Simulated drug disposition in critically ill patients to evaluate effective PK/PD targets for combating Pseudomonas aeruginosa resistance to meropenem},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2024},
  doi = {10.1128/aac.01541-23}
}
Kostenlos starten →